What Are the 3 Stocks That Will Benefit from Covid-19?

By: Submissions

The current coronavirus pandemic has had a massive effect on almost every aspect of the global stock market. In the United States, for instance, the stock market saw an enormous dip around March. This was the worst market crash ever since the infamous 1987 stock market dip in all the 120 years of its history. 

The majority of the shares in South Africa have also deteriorated in value as a result. However, despite all the pressure that companies continue to experience with this pandemic, some have enjoyed good returns. Institutions actively developing vaccines to help curb this menace have a high probability of reaping their exploits' benefits. 

Companies that can do well with remote work are also at an advantage in their pursuit of developing their potential. Here are three companies that are expected to gain from this global pandemic. 

Moderna

Among the industries set to benefit is the pharmaceutical sector at the forefront of fighting the virus. It is a fact that the first company that will get a breakthrough in developing an effective virus will be the biggest winner. Moderna saw its shares hike immediately and the firm revealed that it had already shared vaccine samples for verification by The National Institute of Allergy and Infectious Diseases (NIAID). 

Plans are underway to start trials to determine how viable it is and are set to be initialized in April of next year. One thing that helped Moderna develop this vaccine as quickly as it did was its innovative and efficient strategy in creating medicines. The firm uses RNA technology to do this, which gave it a significant edge in creating this vaccine. 

Interestingly, Moderna has not yet introduced a drug into the market, but investors still invest in the pharmaceutical company. As soon as the vaccine is deemed successful, you can expect that its market shares will only go up.

The Clorox Company 

Since most people are looking to accumulate consumer staples for the future, the Clorox Company will be in a prime position to make money from this development. The product line from this company is mainly bleach, cleaning products, among other sanitary components. 

The demand for its products is at an all-time high, so it wouldn't be surprising if they kept making massive sales globally. In 2020 alone, they have made 6.72 billion worth of sales. The company's shareholders will be happy with the returns on investment they will continue producing.  

Gilead Sciences 

Gilead Sciences is another company that is expected to be at an advantage within this period. The company's market shares have been on a constant rise ever since the news came out that it is in the advanced stages of researching remdesivir, an antiviral drug meant to curb the virus. This is essentially what the company is capitalizing on, which places it at a higher level than its competition. All this is if the drug is established to be a success. 

If it works, you can expect Gilead Sciences to make a lot of money, especially if countries approach the firm for supplies in case of another outbreak in the future. Information from the Center for Disease Control and Prevention (CDC) revealed that this antiviral medicine is already being administered to patients who are in grave condition. This practice is set to go up until there is a better alternative.

By Andrew Cioffi

© 2018 Copyright Andrew Cioffi - All Rights Reserved Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.

© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.